NM Thera
Investor Overview
Confidential 1 / 12

NM Thera presents

SOKY

Spa-grade immersion. Anywhere.

Wearable Soak Platform · Investor Overview
SOKY
Hand & Footcare Reimagined.

What if one of the oldest acts of personal care — immersing the body in water — could move with the person? A patented silicone glove that seals water, warmth, and therapeutic agents around the body. Three SKUs. 200 units. Dropping now.

US Patent · Valid to 2043 3 SKUs · First Drop Now $180K Raised · $3.2M Valuation
NM Therapeutics, Inc. · Delaware C Corp · Pre-Seed
Kenny Pham · Founder & CEO · kenny@nmthera.com · 714-782-2843
The Problem

The bowl is the bottleneck.

Immersion care works. The format doesn't. ~70% of users abandon soak routines within 90 days.

365M+
People affected globally by hand & foot conditions
~70%
Drop-off rate within 90 days
$0
Innovation in the soak format in 50 years
The Core Insight

The science works — warm water, minerals, occlusion, and time are proven. But the delivery format hasn't evolved. SOKY removes the bowl and makes the water move with the person.

The Solution

The seal that pressure makes tighter.

A patented silicone glove that seals water around the body while you move freely.

HandSOKY
Wearable soak glove filled and sealed — product in its active state
300–400%
Hydration under occlusion
80%+
Sweat reduction via iontophoresis
+36 pts
Adherence improvement
9+
Conditions supported
How the Seal Works

The inversion frustal cuff folds inward, creating a pocket. Internal pressure pushes the inner layer more firmly against skin. More pressure = tighter seal. No clamps. No adhesives. No power.

How It Works

Five steps. Every product. Always this order.

The ritual is the platform's shared language. It never changes.

1
Don
Fold cuff inward. Slide on.
2
Fill
Hold seal. Fill under tap.
3
Seal
Ball fist — glove swells = sealed.
4
Soak
15–20 min. Walk. Read. Rest.
5
Drain
Slide off, pour, rinse, dry.
Finger mobility Clasped hands
"Care for the hands is care for everything the hands make possible."
— NM Thera Manifesto, 2026
Market Opportunity

$597B TAM. Zero incumbents.

Category creation, not share capture. The competitor is the bowl.

$597B+
TAM across eight verticals
$5.97B
SAM · Serviceable Addressable
$59.7M
SOM · Serviceable Obtainable
Key Verticals
Hand & Foot Care — $12.2B · First mover
Wellness — $1.5T · Ritual behavior fit
Wearable Med Devices — $34B→$120B · 28% CAGR
Eczema & Skin Care — $145B
Physical Therapy — $39.3B
Anti-Aging — $23.4B+
Acquisition Precedent

PowerDot acquired by Therabody for ~$34M — single-modality, no consumable flywheel. NM Thera Y10 target: $72M (Therabody parity).

Clinical Channel

15-patient dispensing program = ~$15,600 supplemental annual revenue per clinic.

Business Model

Three layers. One port. Recurring revenue.

Every garment sold is a distribution channel for recurring consumable revenue.

1
Garment Base
Silicone glove or sock · Inversion cuff seal · Universal port · US 11,602,631 B2
2
Enhancer Modules
Iontophoresis cap, thermal circulator, sensor pod, ultrasound, fill port — one interface
3
Soak Packs & Formulations
Salts, botanicals, peptide packs, Rx formulations · 75–85% margin · Recurring flywheel
Unit Economics
SKUPriceMargin
Hand SOKY Core$8565–68%
Travel System$15072–77%
SOKY Plus (Salts)$18–3575–85%
Peptide Packs$35–6575–82%
SOKY Rx$750–1KAvailable upon request
Platform Expansion
Now
Hands · Feet
Scale
Arms · Legs
Expand
Knees · Elbows
Beyond
Pelvic
9 Revenue Streams by Year 5

OTC · Rx · Consumables · App · Licensing · Data · Content · Advertising · Clinical Protocols

First Drop · Batch 1

Three SKUs. 200 units.

Every offer ships the same patented glove. Pick the path.

Research Access
_000
$45
Research · 20 units
Research Access
Identical glove. 90-day feedback commitment. Application-based.
Core
_001
$85
Core · 80 units
Hand SOKY
One pair, Size M. The essential starting point.
Travel System
_002
$150
Travel · 100 units
Travel System
Gloves + towel + hook + bag. Gift-ready.
Launch Strategy

Community first. First drop = proof. Sell through → Batch 2 waitlist → Foot SOKY mold (~$15K) funded by revenue. Kickstarter/WeFundr from warm base.

Traction

Not hypothetical. Executing now.

  • 83.8% pre-launch interest rate (109 / 130 prospective users)
  • $70K LOI from leading footcare distributor
  • 5 clinicians actively engaged — protocol conversations underway
  • Dr. Craig Heller (Stanford) — thermoregulation authority — Research Advisor
  • Dr. Salem Lebada — board-certified podiatrist — Clinical Advisor
  • Sean Tan (ex-Huawei) — Manufacturing & Fundraising Advisor
  • TopSheng (ISO 13485) — manufacturer ready, first mold complete
  • Website live — campaign assets deployed, 3 SKUs positioned
$180K
Raised to date
2
Patents
200
Units Batch 1
8 yrs
Development
Intellectual Property

Valid to 2043. No design-around.

The full family of frustal geometries is claimed.

Issued
US 11,602,631 B2 — Hyperhidrosis Treatment
Filed June 2018. Issued March 2023. 15 claims — glove, cuff seal, iontophoresis circuit. Valid through 2043.
Pending
Platform Patent — Localized Immersion
Provisional filed Dec 2025. Claims full frustal geometry family — all body zones, all modalities.
Patent drawing
Patent drawing — inversion cuff seal and port assembly
Regulatory

OTC (Model B/F): Class I, 510(k) exempt — ready now. Rx (Model E): Class II, 510(k) — ISO 13485 via TopSheng.

The Team

Operators across three continents.

Founder · CEO
Kenny Pham
Inventor of SOKY. 8 years of development. BS Neuroscience, UC Riverside. Computational neuroscience, genomics, stem cell biomanufacturing (Calico Life Sciences, PrimeGen Biotech), medical device sales (Blaine Labs, FamilyCord).
Co-Founder · COO
Kenichiro Nishii
BS/MS Bioengineering & Chemical Engineering, Miami University. Led 510(k) submissions at Globizz Corporation. 6 years Lead Regulatory Affairs & Business Development at CureApp North America. Okayama, Japan.
Marketing Director
Chi Le
BS Marketing, Miami University. Growth Marketing at bitFlyer (500% LTV growth YoY), Senior Analyst and Manager at Cerebral (managed multi-million dollar monthly acquisition budget). Los Angeles.
Product Design Engineer
Hameed Kalvathi
Founder of Ideate9. 750+ products designed across 15+ countries. Top 1% CAD designer globally. MS Mechanical Engineering, UTM. Chennai, India.
UX Researcher
Yu Tiffany Morimoto
Master's HCI+Design, UC Irvine. UX Research Lead at CureApp, Design Research Specialist at Accenture Song. Bilingual Japanese-English. Founder of Designacation LLC. Austin, TX.
Content & Brand
Jenn Dau
BBA Marketing, Cal State Fullerton. With NM Thera since 2019. Multichannel marketing across content, social, video production, and graphic design.
Research Advisor
Dr. Craig Heller
Lorry Lokey Professor of Biological Sciences, Stanford University (since 1972). PhD Yale. World authority on thermoregulation and palmar AVA vasculature — the biological foundation of SOKY's clinical thesis.
Clinical Advisor
Dr. Salem Lebada
DPM, Podiatric Medicine, Western University of Health Sciences. BA Neuroscience, UC Riverside. Foot and Ankle Surgeon at HAN Orthopaedics and Foot and Ankle Sports Institute, Los Angeles. Clinical dispensing pathway.
Manufacturing & Fundraising
Sean Tan
Former Director of Technology. Prior: Posifa, AiCare, Huawei. Advises on Model E hardware development and fundraising strategy.
Co-Inventor & Creative
Jennifer Nguyen
Co-inventor of US Patent 11,602,631 B2. Staff Product Designer at Samsara. 10 years building user experiences in B2B SaaS. BA Psychology, UC Irvine.
Legal Counsel · Investor
Seymour Everett
Managing Partner, Everett Dorey LLP, Irvine CA. $30K invested. IP prosecution, corporate structure, and ongoing legal counsel.
Lead Angel Investor
Sosimo Roman
$150K invested. Founding round.
Valuation & Returns

$3.2M. 113× base return.

Bear
$1.5M
IP moat carries the floor
Base ★
$3.2M
First drop succeeds
Bull
$6.5M
LOI converts · Stanford trial
PeriodRevenueMultipleValuationReturn
Now—Asset$3.2M—
Year 2$3.65M3×$12M3.75×
Year 5$48.1M4×$193M60×
Year 10$72M5×$361M113×
Blended Valuation Method

Asset Reconstruction ($1.85M, 35%) + Comparable Transactions ($3.5M, 35%) + Risk-Adjusted DCF ($4.2M, 30%) = $3.13M weighted → $3.2M base case.

The Opportunity

"Your hands deserve meaningful care."

Patented. Portable. Ready to ship. The most asymmetric entry in the company's history.

$3.2M
Valuation
113×
Base Return
$597B+
TAM
Contact Kenny Pham nmthera.com
NM Therapeutics, Inc. · Delaware C Corp
kenny@nmthera.com · 714-782-2843 · Riverside, CA
SOKY supports personal care routines. Not intended to diagnose, treat, cure, or prevent any disease.